Share on StockTwits
 

Analysts at RBC Capital started coverage on shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) in a research report issued to clients and investors on Thursday, StockRatingsNetwork reports. The firm set an “outperform” rating on the stock.

MDRX has been the subject of a number of other recent research reports. Analysts at Maxim Group upgraded shares of Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a research note on Tuesday. They now have a $20.00 price target on the stock. Separately, analysts at Thomson Reuters/Verus upgraded shares of Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a research note on Monday, February 3rd. Finally, analysts at Robert W. Baird raised their price target on shares of Allscripts Healthcare Solutions from $18.00 to $20.00 in a research note on Friday, January 24th. Eight analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $17.36.

Allscripts Healthcare Solutions (NASDAQ:MDRX) traded up 0.66% on Thursday, hitting $16.68. 934,657 shares of the company’s stock traded hands. Allscripts Healthcare Solutions has a 52-week low of $11.04 and a 52-week high of $17.58. The stock’s 50-day moving average is $16.0 and its 200-day moving average is $15.16. The company’s market cap is $2.972 billion.

Allscripts Healthcare Solutions, Inc (NASDAQ:MDRX) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.